Enterprise Value
1.035B
Cash
723.5M
Avg Qtr Burn
N/A
Short % of Float
14.19%
Insider Ownership
0.34%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MVC-COV1901 Details COVID-19 Vaccine | Approved Update | |
COVID-19 S-Trimer (with Clover Biopharmaceuticals) Details Infectious disease, COVID-19 | Approved Quarterly sales | |
Heplisav-B Details Infectious disease, Hepatitis B vaccine, Hepatitis B | Approved Quarterly sales | |
CpG 1018 Details COVID-19 | Approved Quarterly sales | |
Heplisav-B Details Infectious disease, Hepatitis B vaccine, Hepatitis B | BLA Resubmission | |
Phase 2 Data readout | ||
Z-1018 (adjuvanted w/ CpG 1018) Details Shingles, Viral infection, Infectious disease | Phase 1/2 Data readout | |
Tdap-1018 (adjuvanted w/ CpG 1018) Details Tetanus, diphtheria, and pertussis, Infectious disease | Phase 1 Data readout | |
VLA2001 Details Infectious disease, COVID-19 | Failed Discontinued |